Abstract
The fungi Tolypocladium inflatum Gams and Cylindrocarpon lucidum Booth are the producers of a series of cyclic oligopeptides called cyclosporins. To date, about 30 of these natural peptides have been isolated and characterized with respect to their chemical composition and immunopharmacologic properties. All these peptides are structurally related to cyclosporin A, and are composed of 11 amino acids. Usually these peptides differ from cyclosporin A by not more than one amino acid.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Billingham MEJ, Davies GE (1979) Experimental models of arthritis in animals as screening tests for drugs to treat arthritis in man. In: Vane JR, Ferreira SH (eds) Handbook of experimental pharmacology, vol 50/II. Springer, Berlin Heidelberg New York, p 108
Borel JF, Wiesinger D (1977) Effect of cyclosporin A on murine lymphoid cells. In: Lucas DO (ed) Regulatory mechanisms in lymphocyte activation. Academic NY, p 716
Borel JF, Feurer C, Gubler HU, Staehelin H (1976) Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions 6: 468
Borel JF, Feurer C, Magnee C, Staehelin H (1977) Effects of the new antilymphocytic peptide cyclosporin A in animals. Immunology 32: 1017
Brunner KT, Mauel J, Cerottini JC, Chapuis B (1968) Quantitative assay of the lytic action of immune lymphoid cells on 51 Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 14: 181
Dietrich FM, Hess R (1970) Hypersensitivity in mice. I. Induction of contact sensitivity to oxazolone and inhibition by various chemical compounds. Int Arch Allergy 38: 246
Drachman DB, Adams RN, McIntosh K, Pestronk A (1985) Treatment of experimental myasthenia gravis with cyclosporin A. Clin Immunol Immunopathol 34: 174
Dreyfuss M, Haerri E, Hofmann H, Kobel H, Pache W, Tscherter H (1976) Cyclosporin A and C. New metabolites from Trichoderma polysporum (link ex Pers.) Rifai. Eur J Appl Microbiol 3: 125
Ford WL, Burr W, Simonsen M (1970) A lymph node weight assay for the graft-versushost activity of rat lymphoid cells. Transplantation 10: 258
Fulpius BW, Bersinger NA, James RW, Schwendimann B (1981) Isolation and purification of the nicotinic acetylcholine receptor from Torpedo electric organ. In: Azzi A, Brod-beck U, Zahler P (eds) Membrane proteins. Springer, Berlin Heidelberg New York, p 70
Greaves M, Janossy G (1972) Elicitation of selective T and B lymphocyte responses by cell surface binding ligands. Transplant Rev 11: 87
Gunn HC (1985) Successful treatment of autoimmunity in (NZB/NZW)F1 mice with cyclosporine and (Nva2)-cyclosporin. I. Reduction of autoantibodies. Clin Exp Immunol 64: 225
Gunn HC, Ryffel B (1985) Successful treatment of autoimmunity in (NZB/NZW)F1 mice with cyclosporin and (Nva2)-cyclosporine. II. Reduction of kidney pathology. Clin Exp Immunol 64: 234
Hassman RA, Dieguez C, Rennie P, Weetman AP, Hall R, McGregor AM (1985) The influence of cyclosporin A on the induction of experimental autoimmune thyroid disease in the PVG/c rat. Clin Exp Immunol 59: 10
Hiestand PC, Gunn HC, Gale JM, Ryffel B, Borel JF ( 1985 a) Comparison of the pharma-cological profiles of cyclosporine, (Nva2)-cyclosporine and ( Val)dihydrocyclosporine. Immunology 55: 249
Nussenblatt RB, Rodrigues MM, Wacker WB, Cevario SJ, Salinas-Carmona MC, Gery I (1981) Cyclosporin A. Inhibiton of experimental autoimmune uveitis in Lewis rats. J Clin Invest 67: 1228
Israel-Biet D, Noel LH, Bach M-A, Dardenne M, Bach JF (1983) Marked reduction of DNA antibody production and glomerulopathy in thymulin (FTS-Zn) or cyclosporin A treated (NZB x NZW)F1 mice. Clin Exp Immunol 54: 359
Janossy G, Greaves MF (1971) Lymphocyte activation. I. Response of T and B lymphocytes to phytomitogens. Clin Exp Immunol 9: 483
Janossy G, Greaves MF, Doenhoff MJ, Snajdr S (1973) Lymphocyte activation. V. Quantitation of the proliferative responses to mitogens using defined T and B cell population. Clin Exp Immunol 14: 581
Jerne NK, Nordin AA (1963) Plaque formation in agar by single antibody-producing cells. Science 140: 405
Jerne NK, Nordin AA, Henry C (1963) The agar plaque technique for recognizing antibody-producing cells. In: Amos B, Koprowski H (eds) Cell bound antibodies. Wistar Institute, Philadelphia, pp 109
Jones MG, Harris G (1985) Prolongation of life in female NZB/NZW (f1) hybrid mice by cyclosporin A. Clin Exp Immunol 59: 1
Kroenke M, Leonard WJ, Depper JM, Arya SK, Wong-Staal F, Gallo RC, Waldmann TA, Greene WC (1984) Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. Proc Natl Acad Sci USA 81: 5214
Lennon VA, Lindstrom JM, Seybold ME (1975) Experimental autoimmune myasthenia: a model of myasthenia gravis in rats and guinea pigs. J Exp Med 141:1365
Meo T (1979) The MLR in the mouse. In: Lefkovits J, Pernis B (eds) Immunological Methods. Academic NY, p 227
Mishell RI, Dutton RW (1966) Immunization of normal mouse spleen cell suspensions in vitro. Science 153: 1004
Mishell RL, Dutton RW (1967) Immunization of dissociated spleen cell cultures from normal mice. J Exp Med 126: 423
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55
Nussenblatt RB, Rodrigues MM, Wacker WB, Cevario SJ, Salinas-Carmona MC, Gery I (1981) Cyclosporin A. Inhibiton of experimental autoimmune uveitis in Lewis rats. J Clin Invest 67: 1228
Ruegger A, Kuhn M, Lichti H, Loosli HR, Huguenin R, Quiquerez C, Von Wartburg A (1976) Cyclosporin A, ein immunosuppressiv wirksamer Pilzmetabolit aus Trichoderma polysporum ( LINK ex PERS.) Rifai. Helv Chim Acta 59: 1075
Schwartz A, L’age Stehr J, Offermann G (1986) The transfer of LAV/HTLV III infection by renal transplantation. Clinical course in four cases. Klin Wochenschr 64: 200
Shevach EM (1985) The effects of cyclosporin A on the immune system. Ann Rev Immunol 3: 397
Staehelin H (1962) A simple quantitative test for cytostatic agents using nonadhering cells in vitro. Med Exp 7: 92
Stiller CR, Laupacis PA, Keown PA, Gardell C, Dupre J, Thibert P, Wall W (1983) Cyclosporine. Action, pharmacokinetics, and effect in the BB rat model. Metabolism 32: 69
Traber R, Kuhn M, Loosli HR, Pache W, Von Wartburg A ( 1977 a) Neue Cyclopeptide aus Trichoderma polysporum (LINK ex PERS)RIFAI: die Cyclosporine B, D and E. Helv Chim Acta 60: 1568
Vladutiu AO (1983) Effect of cyclosporine on experimental autoimmune thyroiditis in mice. Transplantation 35: 518
Von Wartburg A, Traber R (1986) Chemistry of the natural cyclosporin metabolites. Prog Allergy 38: 28
Wiesinger D, Borel JF (1979) Studies on the mechanism of action of cyclosporin A. Immunobiology 156: 454
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hiestand, P.C., Gubler, H.U. (1988). Cyclosporins: Immunopharmacologic Properties of Natural Cyclosporins. In: Bray, M.A., Morley, J. (eds) The Pharmacology of Lymphocytes. Handbook of Experimental Pharmacology, vol 85. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73217-1_22
Download citation
DOI: https://doi.org/10.1007/978-3-642-73217-1_22
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-73219-5
Online ISBN: 978-3-642-73217-1
eBook Packages: Springer Book Archive